These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19754216)

  • 1. Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies.
    Kunos C; Chen W; DeBernardo R; Waggoner S; Brindle J; Zhang Y; Williams J; Einstein D
    Technol Cancer Res Treat; 2009 Oct; 8(5):393-400. PubMed ID: 19754216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical metastasis as the first manifestation of ovarian papillary serous carcinoma.
    Maki C; Groen J; Delgado B; Piura B
    J Obstet Gynaecol; 2010 Apr; 30(3):325-6. PubMed ID: 20373951
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report.
    Camci C; Sevinc A; Aslan Y; Kalender ME; Buyukberber S
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):745-8. PubMed ID: 18504578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized cancer treatment for ovarian cancer.
    Chumworathayi B
    Asian Pac J Cancer Prev; 2013; 14(3):1661-4. PubMed ID: 23679252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
    Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
    Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Carboplatin-related hypersensitivity reactions in Japanese patients with gynecologic malignancies.
    Koshiba H; Hosokawa K; Kubo A; Miyagi Y; Oda T; Miyagi Y; Watanabe A; Honjo H
    Int J Gynecol Cancer; 2009 Apr; 19(3):460-5. PubMed ID: 19407575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyberknife radiosurgery for squamous cell carcinoma of vulva after prior pelvic radiation therapy.
    Kunos C; von Gruenigen V; Waggoner S; Brindle J; Zhang Y; Myers B; Funkhouser G; Wessels B; Einstein D
    Technol Cancer Res Treat; 2008 Oct; 7(5):375-80. PubMed ID: 18783287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
    Malpica A; Deavers MT
    Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management.
    Grønlund B
    Dan Med Bull; 2006 Aug; 53(3):232-57. PubMed ID: 17092448
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical sigmoid metastasis from a high-grade mixed adenocarcinoma of the ovary.
    Zighelboim I; Broaddus R; Ramirez PT
    Gynecol Oncol; 2004 Sep; 94(3):850-3. PubMed ID: 15350388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
    Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
    Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative radiation therapy in gynecologic cancer: the Mayo Clinic experience.
    Garton GR; Gunderson LL; Webb MJ; Wilson TO; Martenson JA; Cha SS; Podratz KC
    Gynecol Oncol; 1993 Mar; 48(3):328-32. PubMed ID: 8385058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy.
    Desai NB; Kiess AP; Kollmeier MA; Abu-Rustum NR; Makker V; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Dec; 131(3):604-8. PubMed ID: 24055615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
    Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
    Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extensive combined interventions in surgical treatment of locally-advanced neoplasms of organs in the small pelvis].
    Davydov MI; Odariuk TS; Nechushkin MI; Tsar'kov PV; Trigolosov AV; Makarov ES; Zharkov EE
    Vopr Onkol; 1998; 44(5):618-22. PubMed ID: 9884729
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgical implications of mesenteric lymph node metastasis from advanced ovarian cancer after bowel resection.
    Baiocchi G; Cestari LA; Macedo MP; Oliveira RA; Fukazawa EM; Faloppa CC; Kumagai LY; Badiglian-Filho L; Menezes AN; Cunha IW; Soares FA
    J Surg Oncol; 2011 Sep; 104(3):250-4. PubMed ID: 21472733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma.
    Kim MS; Choi C; Yoo S; Cho C; Seo Y; Ji Y; Lee D; Hwang D; Moon S; Kim MS; Kang H
    Jpn J Clin Oncol; 2008 Oct; 38(10):695-700. PubMed ID: 18723850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of surgery in the management of recurrent gynecologic cancer.
    Hogan WM; Boente MP
    Semin Oncol; 1993 Oct; 20(5):462-72. PubMed ID: 7692604
    [No Abstract]   [Full Text] [Related]  

  • 19. Gynecologic oncology.
    Lewis GC
    Semin Drug Treat; 1973; 3(1):101-16. PubMed ID: 4733201
    [No Abstract]   [Full Text] [Related]  

  • 20. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
    Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
    Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.